-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q2 2023 to Q2 2025.
- Neuphoria Therapeutics Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $26,100,000, a 5.78% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)